Khoja Hamid's most recent trade in FibroBiologics Inc was a trade of 20,000 Common Stock done at an average price of $0.8 . Disclosure was reported to the exchange on May 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| FibroBiologics Inc | Hamid Khoja | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 0.84 per share. | 27 May 2025 | 20,000 | 31,250 | - | 0.8 | 16,800 | Common Stock |
| FibroBiologics Inc | Hamid Khoja | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2025 | 189,000 | 189,000 | - | - | Stock Option (Right to Buy) | |
| FibroBiologics Inc | Khoja Hamid | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2024 | 176,200 | 176,200 | - | - | Stock Option (Right to Buy) | |
| FibroBiologics Inc | Hamid Khoja | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 1.90 per share. | 12 Aug 2024 | 10,000 | 11,250 | - | 1.9 | 19,000 | Common Stock |